Announced Wed, 1 Oct · 16:58 IST

As attached.

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Natural Biocon (India) Ltd held its 33rd Annual General Meeting on September 30, 2025, via video conferencing, which concluded in about 19 minutes (12:30 PM to 12:49 PM IST). All 5 ordinary resolutions were passed with overwhelming majority: adoption of audited financial statements for FY ended March 31, 2025 (99.9991% in favor), re-appointment of Managing Director Arunkumar Prajapati (99.7689% in favor), ratification of statutory auditors' appointment to fill a casual vacancy (99.7689% in favor), appointment of statutory auditors for a 5-year term (99.7689% in favor), and appointment of secretarial auditor for a 5-year term (99.7689% in favor). Out of 10,164 total shareholders as on the record date (September 23, 2025), only 59-60 shareholders participated via remote e-voting, representing 52,13,750 shares or about 20.22% of outstanding shares. Notably, the promoter group holding 24,13,000 shares did not cast any votes. PCS Rupal Patel served as the scrutinizer.

Likely market impact

This is a routine procedural disclosure with no material surprise — all standard AGM items (financials, director re-appointment, auditor appointments) cleared with near-unanimous public shareholder support. The notable quirk is that promoters abstained from voting entirely, but since public non-institutional holders alone delivered the required majority, there is no governance concern or price-moving implication.